{"log_id": 507912043703257142, "direction": 0, "words_result_num": 28, "words_result": [{"probability": {"variance": 0, "average": 0.999582, "min": 0.999288}, "location": {"width": 79, "top": 196, "height": 31, "left": 179}, "words": "药效学"}, {"probability": {"variance": 5e-06, "average": 0.998123, "min": 0.993215}, "location": {"width": 150, "top": 242, "height": 34, "left": 184}, "words": "磷酸西格列汀"}, {"probability": {"variance": 3.1e-05, "average": 0.993886, "min": 0.986433}, "location": {"width": 75, "top": 291, "height": 30, "left": 211}, "words": "般信息"}, {"probability": {"variance": 2.1e-05, "average": 0.997362, "min": 0.97879}, "location": {"width": 831, "top": 307, "height": 64, "left": 186}, "words": "在2型糖尿病患者中,磷酸西格列汀能持续24小时抑制DPP-4酶。在口服葡萄"}, {"probability": {"variance": 0.006002, "average": 0.9745, "min": 0.617428}, "location": {"width": 830, "top": 354, "height": 64, "left": 188}, "words": "糖负荷或进餐后,这种对DPP4的抑制能使循环水平的活性GLP-1和GIP浓度"}, {"probability": {"variance": 5e-06, "average": 0.998773, "min": 0.989891}, "location": {"width": 814, "top": 402, "height": 63, "left": 190}, "words": "增加2至3倍,且降低胰高血糖素浓度,增加释放的胰岛素对葡萄糖的应答性"}, {"probability": {"variance": 7.2e-05, "average": 0.997615, "min": 0.950043}, "location": {"width": 830, "top": 448, "height": 66, "left": 192}, "words": "使C肽和胰岛素浓度升高。胰岛素升高以及胰高血糖素降低能使空腹葡萄糖浓"}, {"probability": {"variance": 3.4e-05, "average": 0.997929, "min": 0.969871}, "location": {"width": 601, "top": 505, "height": 56, "left": 193}, "words": "度降低,以及降低口服葡萄糖负荷或进餐后的葡萄糖波动"}, {"probability": {"variance": 0.003652, "average": 0.975677, "min": 0.745196}, "location": {"width": 412, "top": 602, "height": 46, "left": 202}, "words": "磷酸西格列汀和盐酸二甲双胍同时给药"}, {"probability": {"variance": 0.000455, "average": 0.994932, "min": 0.869341}, "location": {"width": 831, "top": 631, "height": 64, "left": 201}, "words": "在一项为期两天的健康受试者研究中,磷酸西格列汀单用能够升高活性GLP-1"}, {"probability": {"variance": 0.000123, "average": 0.993397, "min": 0.949145}, "location": {"width": 830, "top": 678, "height": 63, "left": 202}, "words": "浓度,二甲双胍单用也能够使活性和总GLP-1浓度升高到类似程度。磷酸西格"}, {"probability": {"variance": 0.003923, "average": 0.982436, "min": 0.648801}, "location": {"width": 827, "top": 726, "height": 63, "left": 207}, "words": "列汀和二甲双胍同时给药对活性GLP-1浓度有加合效应。磷酸西格列汀能够升"}, {"probability": {"variance": 4.7e-05, "average": 0.995411, "min": 0.969069}, "location": {"width": 829, "top": 773, "height": 64, "left": 208}, "words": "高活性GIP浓度,但二甲双胍不能。不清楚这些结果对2型糖尿病患者中血糖控"}, {"probability": {"variance": 1e-06, "average": 0.999307, "min": 0.997212}, "location": {"width": 150, "top": 847, "height": 37, "left": 209}, "words": "制变化的意义"}, {"probability": {"variance": 4e-06, "average": 0.998807, "min": 0.989172}, "location": {"width": 670, "top": 875, "height": 56, "left": 212}, "words": "在健康受试者研究中,磷酸西格列汀不能降低血糖或导致低血糖"}, {"probability": {"variance": 0.017284, "average": 0.700423, "min": 0.568953}, "location": {"width": 98, "top": 909, "height": 44, "left": 874}, "words": "约经"}, {"probability": {"variance": 0.000526, "average": 0.978296, "min": 0.945924}, "location": {"width": 150, "top": 983, "height": 33, "left": 219}, "words": "心脏电生理学"}, {"probability": {"variance": 0.004241, "average": 0.978778, "min": 0.680015}, "location": {"width": 826, "top": 1002, "height": 64, "left": 217}, "words": "在一项随机、安慰剂对照的交叉研究中,79例健康受试者接受磷酸西格列汀10"}, {"probability": {"variance": 0.007925, "average": 0.961336, "min": 0.648479}, "location": {"width": 823, "top": 1049, "height": 70, "left": 225}, "words": "mg、磷酸西格列汀800mg(建议剂量的8倍)和安慰剂单次口服给药。在建议"}, {"probability": {"variance": 0.006386, "average": 0.976436, "min": 0.529337}, "location": {"width": 828, "top": 1096, "height": 65, "left": 223}, "words": "剂量100mg下,对峰值血浆浓度时或研究期间其他任意时间所采集的QT间期"}, {"probability": {"variance": 0.004087, "average": 0.984043, "min": 0.609613}, "location": {"width": 829, "top": 1144, "height": 64, "left": 223}, "words": "没有影响。800mg给药后,在给药后3小时安慰剂校正的QTc相对于基线值的"}, {"probability": {"variance": 0.000901, "average": 0.9901, "min": 0.839829}, "location": {"width": 829, "top": 1191, "height": 62, "left": 227}, "words": "平均变化最大增加值为8.0毫秒。该增加被视为没有临床意义。在800mg剂量"}, {"probability": {"variance": 7.6e-05, "average": 0.997087, "min": 0.949036}, "location": {"width": 760, "top": 1239, "height": 61, "left": 233}, "words": "下,磷酸西格列汀血浆浓度的峰值大约是100mg给药后峰值浓度的11倍"}, {"probability": {"variance": 0.00136, "average": 0.988153, "min": 0.798362}, "location": {"width": 831, "top": 1288, "height": 59, "left": 232}, "words": "在2型糖尿病患者中,磷酸西格列汀100mg(N-81)或磷酸西格列汀200mg"}, {"probability": {"variance": 1.3e-05, "average": 0.99841, "min": 0.978804}, "location": {"width": 804, "top": 1331, "height": 63, "left": 256}, "words": "N=63)每天给药,根据在预期峰值血浆浓度时采集的心电图数据,未出现有"}, {"probability": {"variance": 0.001115, "average": 0.986015, "min": 0.887166}, "location": {"width": 224, "top": 1402, "height": 41, "left": 235}, "words": "意义的QTc间期变化"}, {"probability": {"variance": 1e-06, "average": 0.998972, "min": 0.997991}, "location": {"width": 75, "top": 1498, "height": 28, "left": 241}, "words": "毒理学"}, {"probability": {"variance": 5.2e-05, "average": 0.991781, "min": 0.984603}, "location": {"width": 50, "top": 1545, "height": 29, "left": 247}, "words": "本品"}], "language": 3}